Meclizine Hydrocloride recalls
The FDA has published 2 recalls involving Meclizine Hydrocloride since 2017. The latest was reported on 6 Apr 2022. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2017
Last 12 months0reported
Class I150% of total
Ongoing0latest 6 Apr 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 50%Class II 0 0%Class III 1 50%
Why meclizine hydrocloride is recalled
Companies
By year
All meclizine hydrocloride recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Meclizine Hydrochloride Tablets USP, 12.5 mg recalledMeclizine Hydrochloride | Jubilant Cadista Pharmaceuticals | Labeling Errors | 5 states |
| Drug | CLASS III | Meclizine hydrochloride tablets USP, 12.5 mg HDPE recalledMeclizine Hydrochloride | Jubilant Cadista Pharmaceuticals | Other | Nationwide |
Should you stop taking Meclizine Hydrocloride?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.